04:31 PM EDT, 08/12/2026 (MT Newswires) -- Claire Mazumdar, Director, Chief Executive Officer, on August 10, 2026, sold 10,000 shares in Bicara Therapeutics ( BCAX ) for $279,750. Following the Form 4 filing with the SEC, Mazumdar has control over a total of 362,152 common shares of the company, with 362,152 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2023658/000147083126000813/xslF345X05/wk-form4_1786565953.xml